Non-Hallucinogenic Psilocybin & Mental Health: Diamond Therapeutics’ Historic Clinical Trial Begins Nov 24, 2021
Ibogaine Addiction Treatments & MDMA Assisted-Psychotherapy: MINDCURE & The State Of Psychedelic Therapeutics… Nov 23, 2021
Study Shows Promise In Cure For Alzheimers: MYND Life Sciences Looks To Biomarkets In Fight Against Mental Disease Nov 23, 2021
Catching Up With PharmaDrug CEO Daniel Cohen On COVID-19 Treatments And Psychedelic Research Strategy Nov 23, 2021
Numinus CEO Payton Nyquvest Says Psychedelic Therapy Shouldn’t Be The ‘Last’ Option For Treatment Nov 21, 2021
